TABLE 1

Clinical characteristics

Control subjectsDiabetic subjectsP
n1010
Duration of diabetes (years)2.6 ± 0.5
Age (years)51.1 ± 2.050.4 ± 1.6NS
BMI (kg/m2)29.6 ± 0.931.1 ± 1.1NS
Fat-free mass (kg)64.1 ± 2.363.6 ± 1.8NS
HbA1c (%)5.1 ± 0.16.9 ± 0.5<0.01
Fasting plasma triglycerides (mmol/l)1.4 ± 0.23.4 ± 0.80.02
Fasting cholesterol (mmol/l)5.6 ± 0.35.7 ± 0.2NS
Fasting serum C-peptide (pmol/l)657 ± 551051 ± 115<0.01
Fasting serum insulin (pmol/l)48 ± 774 ± 90.03
Fasting plasma glucose (mmol/l)5.7 ± 0.110.7 ± 1.2<0.01
Fasting serum FFA (mmol/l)0.53 ± 0.070.51 ± 0.06NS
  • Data are means ± SE. Clinical characteristics of type 2 diabetic and control subjects.

    NS, not significant.